Functional Uncoupling of the Janus Kinase 3-Stat5 Pathway in Malignant Growth of Human T Cell Leukemia Virus Type 1-Transformed Human T Cells1

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Immunology

• Publication date

  2000-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.165.9.5097PMID 11046040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.

  1999cited by this paper
• Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells.

  1999cited by this paper
• Binding of c-Rel to STAT5 target sequences in HTLV-I-transformed T cells

  1999cited by this paper
• Tyrphostin AG‐490 inhibits cytokine‐mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen‐activated human T cells

  1999cited by this paper
• Differential Control of the Phosphorylation State of Proline-juxtaposed Serine Residues Ser725 of Stat5a and Ser730 of Stat5b in Prolactin-sensitive Cells*

  1998cited by this paper
• HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation

  1998cited by this paper
• Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.

  1998cited by this paper
• Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.

  1998cited by this paper
• Constitutive activation of Jak‐2 and Tyk‐2 in a v‐Src‐transformed human gallbladder adenocarcinoma cell line

  1998cited by this paper
• Human and Simian T-Cell Leukemia Viruses Type 2 (HTLV-2 and STLV-2pan-p) Transform T Cells Independently of Jak/STAT Activation

  1998cited by this paper
• HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation.

  1998cited by this paper
• Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site

  1998cited by this paper
• Ser727‐dependent recruitment of MCM5 by Stat1α in IFN‐γ‐induced transcriptional activation

  1998cited by this paper
• Expression of signal transducers and activators of transcription proteins in acute myeloid leukemia blasts.

  1998cited by this paper
• Constitutive activation of TCR signaling molecules in IL-2-independent Herpesvirus saimiri-transformed T cells.

  1998cited by this paper
• Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation

  1998cited by this paper
• Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site.

  1998cited by this paper
• Stat3 Activation Is Required for Cellular Transformation by v-src

  1998cited by this paper
• Clonal expansion within CD4+ and CD8+ T cell subsets in human T lymphotropic virus type I-infected individuals.

  1998cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients.

  1997cited by this paper
• The role of Jak3 in lymphoid development, activation, and signaling.

  1997cited by this paper
• STAT3 Is a Serine Kinase Target in T Lymphocytes

  1997cited by this paper
• B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

  1997cited by this paper
• Prolactin Stimulates Serine/Tyrosine Phosphorylation and Formation of Heterocomplexes of Multiple Stat5 Isoforms in Nb2 Lymphocytes*

  1997cited by this paper
• Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins.

  1997influential reference
• Two Discrete Regions of Interleukin-2 (IL2) Receptor β Independently Mediate IL2 Activation of a PD98059/Rapamycin/Wortmannin-insensitive Stat5a/b Serine Kinase*

  1997cited by this paper
• Human T cell leukemia virus type I (HTLV-I) and human diseases.

  1997cited by this paper
• Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways

  1997cited by this paper
• Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-γ and interleukin-4 receptor-α

  1996cited by this paper
• Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

  1996cited by this paper
• Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.

  1996cited by this paper
• Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB

  1996cited by this paper
• Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.

  1996cited by this paper
• Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line HuT-102 is associated with a human T-cell lymphotrophic virus type I region /IL-15 fusion message that lacks many upstream AUGs that normally attenuates IL-15 mRNA translation.

  1996cited by this paper
• Human T-cell lymphotropic virus type 1 Tax mediates enhanced transcription in CD4+ T lymphocytes

  1996cited by this paper
• Activation and association of Stat3 with Src in v-Src-transformed cell lines

  1996cited by this paper
• IL4 and IL13 receptors share the γc chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells

  1996cited by this paper
• Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation.

  1995cited by this paper
• Requirement of serine phosphorylation for formation of STAT-promoter complexes.

  1995cited by this paper
• Tyrosine kinase inhibition: an approach to drug development.

  1995cited by this paper
• Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.

  1995cited by this paper
• Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

  1995cited by this paper
• Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.

  1995cited by this paper
• An amino acid substitution in the Drosophila hopTum‐l Jak kinase causes leukemia‐like hematopoietic defects.

  1995cited by this paper
• Tyrosine kinase inhibition: an approach to drug development.

  1995cited by this paper
• Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa B

  1994cited by this paper
• Stable growth transformation of human T lymphocytes by herpesvirus saimiri.

  1992cited by this paper
• Type I human T cell leukemia virus tax protein transforms rat fibroblasts through the cyclic adenosine monophosphate response element binding protein/activating transcription factor pathway.

  1991cited by this paper
• Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase.

  1991cited by this paper
• Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases.

  1991cited by this paper
• In vivo cellular tropism of human T-cell leukemia virus type 1

  1990cited by this paper
• Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.

  1990cited by this paper
• The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells

  1990cited by this paper
• Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors.

  1989cited by this paper
• c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.

  1988cited by this paper
• Induction of interleukin 2 receptor gene expression by p40x encoded by human T‐cell leukemia virus type 1.

  1986cited by this paper
• Antibodies to adult t‐cell leukemia‐virus‐associated antigen (atla) in sera from patients with atl and controls in japan: A nation‐wide sero‐epidemiologic study

  1982cited by this paper
• Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

  1981cited by this paper
• Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

  1980influential reference

• STAT 3 and STAT 5 A are potential therapeutic targets in castration-resistant prostate cancer

  2018cites this paper
• STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer

  2017cites this paper
• STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I–Transformed and ATL Cells

  2015cites this paper
• [SOCSJ gene mutations in patients with diffuse large B-cell lymphoma].

  2015cites this paper
• miR-28-3p Is a Cellular Restriction Factor That Inhibits Human T Cell Leukemia Virus, Type 1 (HTLV-1) Replication and Virus Infection*

  2015cites this paper
• IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter

  2014cites this paper
• IL-2 Enhances Cervical Cancer Cells Proliferation and JAK3/STAT5 Phosphorylation at Low Doses, While at High Doses IL-2 Has Opposite Effects

  2014cites this paper
• STAT5 signaling in expression of the α-subunit of interleukin-2 receptor in human blood lymphocytes

  2013cites this paper
• Rac 1 Protein Regulates Glycogen Phosphorylase Activation and Controls Interleukin ( IL )-2-dependent T Cell Proliferation

  2012cites this paper
• Signal Transducer and Activator of Transcription 5b (Stat5b) Serine 193 Is a Novel Cytokine-induced Phospho-regulatory Site That Is Constitutively Activated in Primary Hematopoietic Malignancies*

  2012cites this paper
• JAK3/STAT5 signaling cascade represents a therapeutic target to treat select hematologic malignancies

  2012cites this paper
• Human T-lymphotropic virus proteins and post-translational modification pathways.

  2012cites this paper
• Molecular Hallmarks of Adult T Cell Leukemia

  2012cites this paper
• Rac1 Protein Regulates Glycogen Phosphorylase Activation and Controls Interleukin (IL)-2-dependent T Cell Proliferation*

  2012cites this paper
• Tyrphostin AG490 Agent Modestly but Significantly Prevents Onset of Type 1 in NOD Mouse; Implication of Immunologic and Metabolic Effects of a Jak-Stat Pathway Inhibitor

  2012cites this paper
• Interfering with interferon‐γ signalling in intestinal epithelial cells: selective inhibition of apoptosis‐maintained secretion of anti‐inflammatory interleukin‐18 binding protein

  2011cites this paper
• CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.

  2011cites this paper
• STAT5 regulates glioma cell invasion by pathways dependent and independent of STAT5 DNA binding.

  2011cites this paper
• STAT5 in regulation of chronic leukemia K562 cell proliferation: Inhibitory effect of WHI-P131

  2010cites this paper
• Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathways

  2010cites this paper
• Uncoupling JAK3 activation induces apoptosis in human lymphoid cancer cells via regulating critical survival pathways

  2010cites this paper
• Deguelin suppresses cell proliferation via the inhibition of survivin expression and STAT3 phosphorylation in HTLV-1-transformed T cells.

  2010cites this paper
• Targeted therapy in T-cell malignancies : dysregulation of the cellular signaling pathways

  2009cites this paper
• Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells.

  2008cites this paper
• HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches

  2008cites this paper
• A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490.

  2008cites this paper
• Telomerase Regulation and Telomere Maintenance during Human T-cell Leukemia/Lymphoma Virus (HTLV-I) Transformation

  2008cites this paper
• Kaempferol Inhibits IL-4-Induced STAT6 Activation by Specifically Targeting JAK31

  2007cites this paper
• Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression.

  2007cites this paper
• HTLV-1, Cytokines,and Cancer

  2007cites this paper
• Regulation of T cell homeostasis by JAKs and STATs

  2007cites this paper
• Activation by Specifically Targeting JAK 3 Kaempferol Inhibits IL-4-Induced STAT 6 Zamorano

  2007cites this paper
• Human T cell leukemia virus type 1 Tax‐induced signals in cell survival, proliferation, and transformation

  2007cites this paper
• Activation by Specifically Targeting JAK3 Kaempferol Inhibits IL-4-Induced STAT6

  2007cites this paper
• Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia.

  2006cites this paper
• HIV-1, AIDS, and Related Malignancies

  2006cites this paper
• This information is current as Survival of a Human Lymphoid Tumor Constitutively Active STAT 3 , in Promoting A Preferential Role for STAT 5 , not

  2006cites this paper
• Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells

  2006cites this paper
• A Preferential Role for STAT5, not Constitutively Active STAT3, in Promoting Survival of a Human Lymphoid Tumor1

  2006cites this paper
• Molecular mechanisms of cellular transformation by HTLV-1 Tax

  2005cites this paper
• Cell biology of IL-7, a key lymphotrophin.

  2005cites this paper
• Down-regulation of SHP1 and up-regulation of negative regulators of JAK/STAT signaling in HTLV-1 transformed cell lines and freshly transformed human peripheral blood CD4+ T-cells.

  2004cites this paper
• Regulation of lymphoid cell apoptosis by Jaks and Stats.

  2004cites this paper
• A new modality for immunosuppression: targeting the JAK/STAT pathway

  2004cites this paper
• Temporal variations in protein tyrosine kinase activity in leukaemic cells: Response to all-trans retinoic acid

  2003cites this paper
• Signal transducer and activator of transcription proteins in leukemias.

  2003cites this paper
• Roscovitine Inhibits STAT 5 Activity and Induces Apoptosis in the Human Leukemia Virus Type 1-Transformed Cell Line MT2

  2003cites this paper
• Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2.

  2003cites this paper
• T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1

  2003cites this paper
• EXPRESSION CHANGES OF BOVINE LEUKAEMIA VIRUS GENES UNDER THE IMPACT OF TYROSINE KINASE INHIBITORS - GELDANAMYCIN AND TYRPHOSTIN

  2003cites this paper
• Seizing of T cells by human T-cell leukemia/lymphoma virus type 1.

  2003cites this paper
• Allochimeric class I MHC protein-induced tolerance by partial TCR engagement requires activation of both CTL4- and common &ggr;-chain-dependent cytokine signals1

  2002cites this paper
• Interleukin‐2 family cytokines stimulate phosphorylation of the Pro‐Ser‐Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways

  2002cites this paper
• HTLV-1 cell lines differ in constitutively activated signaling pathways that can be altered by cytokine exposure.

  2001cites this paper
• The role of signals 1, 2, and 3 in induction of transplantation tolerance.

  2001cites this paper